HIV testing recommendations in guidelines and practice

HIV testing recommendations in guidelines and practice - HeLP

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00028743

Enrollment

196

Registered

2023-02-17

Start date

2024-01-05

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV indicator diseases B20-B24

Interventions

Group 1: The intervention/observation group split is not applicable to the present study. In this study, routine data of the Wissenschaftliches Institut der AOK as well as data of the Robert Koch Ins

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: outpatient physician

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
HIV incidences in HIV indicator diseases	—

Secondary

Measure	Time frame
HIV incidences in HIV indicator diseases stratified by age and sex; existence of German guidelines on validated HIV indicator diseases; mention of HIV in these guidelines; mention of HIV testing in these guidelines; recommendation of HIV testing in these guidelines; reasons for (not) including the recommendation on HIV testing when creating/updating these guidelines; reasons in practice for not offering HIV testing despite HIV testing recommendations in guidelines; awareness of HIV testing recommendation in guidelines regarding HIV indicator diseases; measures to increase HIV testing rates in validated HIV indicator diseases.	—

Measure

Time frame

HIV incidences in HIV indicator diseases stratified by age and sex; existence of German guidelines on validated HIV indicator diseases; mention of HIV in these guidelines; mention of HIV testing in these guidelines; recommendation of HIV testing in these guidelines; reasons for (not) including the recommendation on HIV testing when creating/updating these guidelines; reasons in practice for not offering HIV testing despite HIV testing recommendations in guidelines; awareness of HIV testing recommendation in guidelines regarding HIV indicator diseases; measures to increase HIV testing rates in validated HIV indicator diseases.

—

Countries

Germany

Contacts

Public ContactFrederik Valbert

Lehrstuhl für Medizinmanagement, Universität Duisburg-Essen

frederik.valbert@medman.uni-due.de(+49) 0201 / 183-4077

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 10, 2026